Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting
NCT ID: NCT01148693
Last Updated: 2011-09-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
114 participants
INTERVENTIONAL
2009-12-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis
NCT02594891
Non-inferiority of Pharmacological Prevention Alone Versus Pancreatic Stents to Prevent Post-ERCP Pancreatitis
NCT02368795
CBD Stenting vs Non-Stenting for Choledocholithiasis
NCT07331142
*Effect of Prophylactic CBD Stenting Versus Non Stenting on Recurrence of CBD Stones in Patients Awaiting Cholecystectomy*
NCT07084493
Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD
NCT01673269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
gentamicin
adding 10mg gentamicin to every 10 ml of contrast media
gentamicin
10mg per 10ml of contrast media
Placebo
Identical placebo
gentamicin
10mg per 10ml of contrast media
Placebo
Distilled water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
gentamicin
10mg per 10ml of contrast media
Placebo
Distilled water
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Leukocytosis (WBC \> 10,000 /mm3)
* Not candidate for surgical cure of obstruction
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tehran University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alireza Norouzi
gastroenterology fellow in DDRC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rasoul Sotudemanesh, MD
Role: STUDY_CHAIR
Tehran Medical University of Medical Science associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TUMS Digestive Disease Research Center
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Norouzi A, Khatibian M, Afroogh R, Chaharmahali M, Sotoudehmanesh R. The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for non-calculous biliary obstruction, a randomized controlled trial. Indian J Gastroenterol. 2013 Jan;32(1):18-21. doi: 10.1007/s12664-012-0208-y. Epub 2012 Oct 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DDRC-88/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.